Top Industry Leaders in the Vitiligo Treatment Market
Latest Vitiligo Treatment Companies Update
-
Oct 2023: To demonstrate its expertise and leadership on industry challenges and tendencies in packaging and containment, West Pharmaceutical Services, Inc., a global leader in inventive solutions for injectable drug administration, today announced that it will take part in the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Meeting in Gothenburg, Sweden. West is constantly growing and improving our range of premium drug delivery systems and packaging to offer system solutions for ever more complex and delicate compounds.
-
Jan 2023: Data from a Phase II CUV156 research, including afamelanotide, a melanocortin medication, in patients with xeroderma pigmentosum (XP), have been released by Clinuvel Pharmaceuticals. The trial aimed to evaluate the safety of afamelanotide in patients with XPC. It also assessed the medication's capacity to aid the skin's healing processes following UV light-induced DNA damage. Ten weeks were spent on it, and a follow-up was done after six months. Six afamelanotide doses were administered to trial participants, coupled with controlled UVB radiation on unexposed skin areas (the buttocks), and DNA markers were assessed.
List of Vitiligo Treatment Key companies in the market
- Novartis AG
- Allergan Inc.
- Clinuvel Pharmaceuticals Limited
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- STRATA Skin Sciences
- Reddy's Laboratories Ltd.
- Eli Lilly Company
- Incyte Corporation